Follow-The-Filings

Security

C4 Therapeutics Inc. · COM STK

Equity holders as of 2026 Q1 (each manager’s latest book)

9 owners max 0.0% (Renaissance Technologies LLC)

owners 9
max % 0.0%
tracked value $32M
qoq A 5 R 2

holders

sorted by % of portfolio · long equity only

manager % port activity shares value history
Renaissance Technologies LLC 2026 Q1 0.0% Add +0.01 pp 2,461,815 $6M hist
Vanguard Group Inc. 2025 Q4 stale 0.0% Add 0.00 pp 4,379,815 $8M hist
Ken Griffin - Citadel Advisors LLC 2026 Q1 0.0% Add 0.00 pp 2,511,015 $7M hist
Israel Englander - Millennium Management LLC 2026 Q1 0.0% Add 0.00 pp 1,393,342 $4M hist
Two Sigma Investments, LP 2025 Q4 stale 0.0% Exit 0.00 pp 1,509,603 $3M hist
D. E. Shaw & Co., Inc. 2026 Q1 0.0% Add 0.00 pp 1,060,331 $3M hist
Steve Cohen - Point72 Asset Management, L.P. 2026 Q1 0.0% Reduce -0.02 pp 169,096 $445 hist
Marshall Wace - Marshall Wace, LLP 2026 Q1 0.0% Reduce 0.00 pp 155,495 $409 hist
Farallon Capital Management LLC 2026 Q1 0.0% 28,000 $74 hist

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $20.76M $35.58M $35.95M
Gross profit
Gross margin
Net income -$132.49M -$105.32M -$104.99M
Net margin * -638.3% -296.0% -292.1%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $271.19M $257.77M $258.11M
Total non-current assets * $105.26M $91.84M $100.96M
Total assets $376.45M $349.6M $359.08M
Total current liabilities $42.77M $45.18M $33.03M
Total non-current liabilities * $87.57M $88.44M $69.46M
Total equity $246.11M $215.99M $256.59M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$106.84M -$65.16M -$98.69M
Cash from investing $158.35M -$51.27M -$8.6M
Cash from financing $45.49M $45.34M $126.4M
Net change in cash $97M -$71.09M $19.1M

ownership over time

filing count by report period · click a bar for that quarter’s holders